With a market valuation of ₹509.10 Cr, Zim Laboratories Ltd. is a small capitalization company active in the pharmaceutical industry. The company is involved in the development, production and delivery of specific generic pharmaceutical products in solid oral doses in addition to providing finished formulations (FF) and pre-formulation intermediates (PFI) for a number of major therapeutic categories. . The company released its second quarter results along with a 2:1 free share issue.
- HDT Bio Receives Procedural Notice from FDA for US Phase 1 Clinical Trial of COVID-19 RNA Vaccine | Vaccines
- Exceptional measure! The National Pharmaceutical Prices Authority authorizes a 50% PRICE INCREASE on THESE MEDICINES; wording that increases corporate shares by up to 10%
- Hangzhou Chance Pharmaceuticals Announces Acceptance of NMPA
- Delivering CBD with MCT Oil